Jim Reznick

jim-reznick-372x372

Jim W. Reznick

Advisor
Primary Specialty:  Cardiologist
Experience: 34 Years

Medical Education: Doctor of Osteopathic Medicine from the New York College of Osteopathic Medicine in Old Westbury, New York

Postgraduate training at Metropolitan Hospital in Philadelphia, Pennsylvania, and at Chicago Osteopathic Medical Center, Chicago, Illinois.
Internship training, a residency in internal medicine and a fellowship in cardiology.

Licensed to practice medicine in Arizona and California (active status) as well as in Illinois, Pennsylvania and Texas (inactive status).

Biography

Dr James Reznick is a renowned Doctor of Osteopathic Medicine in Newport Beach, California, based with more than thirty-six years expertise as a leading interventional, clinical and consultant cardiologist. As a Fellow of the American College of Cardiology, Dr. Reznick is a recognized leader in cardiovascular care with a passion to improve heart health in the patients he treats. In addition to having a practice affiliation with Hoag Memorial Hospital Presbyterian, Newport Beach, Dr. Reznick has gained national reputation in the field of cardiology and finds himself providing expert care in cardiology in both Arizona and California. 

 

An expert consultant to the Osteopathic Medical Board of California, Dr. Reznick earned his Bachelor of Arts from Oberlin College, Oberlin, Ohio in Biology and his Doctor of Osteopathic Medicine from the New York College of Osteopathic Medicine in Old Westbury, New York.

 

Dr. Reznick undertook postgraduate training at Metropolitan Hospital in Philadelphia, Pennsylvania, and at Chicago Osteopathic Medical Center, Chicago, Illinois, completing his internship training, a residency in internal medicine and a fellowship in cardiology. Dr. Reznick is licensed to practice medicine in Arizona and California (active status) as well as in Illinois, Pennsylvania, and Texas (inactive status).

 

Dr. Reznick is currently a member of the Medical Advisory Board of Newport Beach, California, based Colidion, Inc., a company that develops, acquires and licenses novel assets in healthcare including Spectrum Antimicrobials (focused on developing multiple anti-infective technologies for patients) and Plex Pharmaceuticals (focused on improve the lives of patients afflicted with complex diseases and disorders including Parkinson’s disease, glioblastoma and cataracts).

 

Dr. Reznick brings to Ostentus a wealth of expertise in non-oncological medical practice and a record of advising on entrepreneurialism in medicine that will prove valuable to the Advisory board at Ostentus.